Product Details
Metrix® COVID-19 test is a nucleic acid amplification test (NAAT). It detects all the prevalent COVID-19 variants with high sensitivity. Metrix delivers lab-quality results in under 30 minutes, so that you can catch infection before symptoms start, seek timely treatment, and stop the spread.
Metrix® COVID-19 test is safe for use with individuals aged 14 or older, and for children aged 2 or older when assisted by an adult, including for individuals without symptoms.
All Metrix® tests need to be used in conjunction with the Metrix® Reader
The Metrix® COVID-19 test 25pk package includes sufficient nasal swabs, collectors, caps, and sensors to perform 25 tests, as well as one Quick Reference Instructions (QRI).
Sample, Snap, Slide. All Set.
You can also watch the demo video below:
Swab
sample: Metrix® COVID-19 Test - Swab
Saliva
sample: Metrix® COVID-19 Test - Saliva
If
you encounter any difficulties in using the product, please contact us at support@aptitudemetrix.com.
For answers to the most commonly asked questions, please visit our Help Center.
Although antigen tests are cheaper than molecular
tests, they suffer from a much higher risk of yielding false results1. In
consequence, FDA requires all antigen tests to be performed repeatedly over several
days to improve their performance2.
However, this not only multiplies
the cost, but more importantly, delays the correct diagnosis, and risks missing
the optimal window for treatment.
Aptitude Metrix® tests are comparable in
cost to repeat antigen testing, and put your mind at ease by delivering
PCR-quality results from the get-go.
1 Rapid,
point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection
- PubMed (nih.gov)
2 In Vitro Diagnostics EUAs - Antigen Diagnostic Tests for
SARS-CoV-2 | FDA
Aptitude Metrix® is the only OTC molecular testing platform that delivers best in class performance while combining ease-of-use, versatility, and affordability.
This product has not been FDA cleared or approved, but has been authorized for
emergency use by FDA under an EUA;
This product has been authorized only for the detection of nucleic acid from
SARS-CoV-2, not for any other viruses or pathogens; and
The emergency use of this product is only authorized for the duration of the
declaration that circumstances exist justifying the authorization of emergency use
of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section
564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 360bbb3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
View Product
Authorization for Metrix® COVID-19 Test.
